Streetbeat News

SIEN

Sientra Inc

http://sientra.com/

CEO

Jeffrey Nugent

Employees

234

Industry

Surgical and Medical Instrument Manufacturing

medical devices- plastic surgery: aesthetic and reconstructive, urology

Open

0.18

Mkt cap

2.1M

Volume

3.3M

High

0.20

P/E Ratio

-0.03

52-wk high

4.94

Low

0.16

Div yield

N/A

52-wk low

0.16

Fluor Corporation's shares fell by 7.7% following its Q4 results, with earnings beating estimates but sales missing expectations. Other stocks moved significantly in Tuesday's session, with notable gainers including TRxADE HEALTH, AgriFORCE Growing Systems, and Monopar Therapeutics, among others, due to various positive announcements. Losers included RAPT Therapeutics, MicroCloud Hologram, and Summit Therapeutics, primarily due to negative news or disappointing results.

Portfolio Pulse from Avi Kapoor

February 20, 2024 | 6:21 pm

In Tuesday's intraday session, several healthcare stocks experienced significant movements. Monopar Therapeutics led the gainers with a 138.8% increase, while RAPT Therapeutics saw the largest decline at 66.2%. Other notable movers include Trxade Health, Biofrontera, Iovance Biotherapeutics, and SeaStar Medical Holding among the gainers, and Summit Therapeutics, Better Therapeutics, Universe Pharmaceuticals, Sientra, and Tenaya Therapeutics among the losers.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 5:31 pm

In Tuesday's pre-market session, several healthcare stocks showed significant movement. Trxade Health (MEDS) led the gainers with a 207.2% increase, while RAPT Therapeutics (RAPT) experienced the largest drop among the losers, declining by 67.3%. Other notable movers include Biofrontera (BFRI) with a 206.87% increase and Ocugen (OCGN) rising by 28.54%. The movements reflect significant volatility in the healthcare sector.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 1:05 pm

In Monday's after-market session, several health care stocks showed significant movement. Trxade Health (MEDS) saw a notable increase of 105.3%, while Universe Pharmaceuticals (UPC) experienced a significant decrease of 27.6%. Other stocks such as Iovance Biotherapeutics (IOVA) and Virpax Pharmaceuticals (VRPX) also saw upward movements, whereas companies like Sientra (SIEN) and Femasys (FEMY) faced declines.

Portfolio Pulse from Benzinga Insights

February 19, 2024 | 9:30 pm

In Friday's pre-market session, several healthcare stocks showed significant movement. Gainers included China SXT Pharmaceuticals, MediciNova, Sarepta Therapeutics, Ikena Oncology, Sientra, and Artivion, with increases ranging from 10.86% to 25.2%. Losers were Inventiva, T2 Biosystems, Healthcare Triangle, Hepion Pharmaceuticals, Cardio Diagnostics Hldgs, and AMN Healthcare Services, with decreases ranging from 7.26% to 8.6%. Notably, earnings reports influenced several of these movements.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 1:06 pm

Healthcare stocks experienced significant movements in Thursday's intraday session. Sientra led the gainers with a 193.5% increase, while Renalytix faced the largest drop among the losers, decreasing by 32.2%. Notably, American Well's stock rose after Q4 earnings, and Renalytix and Palatin Techs saw declines following their Q2 earnings announcements.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 5:31 pm

Trading of Sientra shares has resumed, indicating a return to normal trading activities for the company.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 4:31 pm

Shares of Sientra (SIEN) were halted on a circuit breaker due to a significant upside movement, with the stock now up 510.9%. This dramatic increase in stock price indicates a highly volatile trading session for SIEN, attracting considerable investor attention.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 4:25 pm

Trading of Sientra Inc. shares has resumed, indicating a return to normal trading activities for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 4:13 pm

Shares of Sientra (SIEN) were halted on a circuit breaker due to a significant uptick, with the stock now up 333.2%. This dramatic increase in stock price indicates a highly volatile trading session for SIEN, attracting considerable investor attention.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 4:08 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.